Project Grant R35GM158171
Award Date
8/1/25
Completion Date
5/31/30
Dollars Obligated
$577K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) will support research at Northwestern University on how RNA modifications regulate translation initiation and cellular stress responses. The $440,000 award, effective August 1, 2025 through May 31, 2030, will integrate biochemistry, chemical biology, transcriptomics, and cell biology approaches to investigate how the epitranscriptome...
This Project Grant award for $466,125.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training federal grant program (CFDA 93.859). The award supports a research project at New York University School of Medicine to identify and characterize key metabolic control mechanisms, with a focus on understanding cellular mechanisms for sensing pyrimidine levels and iron availability. The project will develop cell and mouse models to...
This Project Grant award of $388,621 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support the development of novel molecular designs with therapeutic potential. The key objectives are: Developing ligand-heterocycle conjugates as targeted RNA degraders with rapid kinetics and selectivity for cancer-associated G-quadruplexes. Engineering nucleic acid polymers with (thio)phosphoramidate backbones as biostable...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Federal Grant Program (CFDA 93.859), supports research into the post-transcriptional control of gene expression by the mTORC1 signaling pathway. The $1,675,000 award to Yale University, spanning August 2024 to June 2029, will fund research to understand the molecular mechanisms that regulate mRNA translation and stability in response to nutrient...
This Project Grant award, valued at $1,380,568.00 and provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program, supports an interdisciplinary research initiative led by the University of Chicago. The project aims to develop a multiscale, predictive understanding of how cells adapt to changes in their environment, with potential applications in innovative therapeutic interventions for diseases. The research is...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $544,478 to The University of Texas Southwestern Medical Center to conduct research on "Decoding the Metabolic Routes of Purine Nucleotides in Cancer". The overarching goal is to expand the mechanistic understanding of purine synthesis pathways in tumors and identify new strategies to target purine supply mechanisms for effective cancer treatment. Key research aims include:...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $762,960 to the University of Texas at Austin to develop localized real-time sensors for monitoring intracellular metabolic signaling. The research aims to deconvolute the signaling roles of metabolites by creating genetically encoded fluorescent biosensors that can measure specific metabolite concentrations and fluctuations within...
This Project Grant award, with a total funding of $450,313, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant supports research to elucidate the molecular mechanisms that underlie the dynamic behavior of multidomain enzymatic factories known as nonribosomal peptide synthetases (NRPSs). The awardee, The Johns Hopkins University, will leverage nuclear magnetic resonance (NMR)...
This federal Project Grant award of $393,149 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research at Brandeis University to study the regulation of PPM family serine/threonine phosphatases. The overarching goal is to address two key gaps in knowledge about reversible protein phosphorylation: how phosphatases are regulated and targeted to specific substrate phosphorylation sites. The...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $421,600 to The Morgridge Institute for Research, Inc. to understand how metabolic conditions influence the behavior of human cells. The key products and services to be delivered under this 5-year award include: Elucidating genetic and environmental contributions to human cell fitness and growth, leveraging innovative tools such as a...